Jaguar Health Inc (NASDAQ:JAGX) shares were up 3.4% during mid-day trading on Wednesday . The stock traded as high as $0.61 and last traded at $0.60. Approximately 67,489 shares changed hands during trading, a decline of 92% from the average daily volume of 858,270 shares. The stock had previously closed at $0.58.
The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.33 and a current ratio of 0.56.
A hedge fund recently bought a new stake in Jaguar Health stock. Acadian Asset Management LLC purchased a new position in shares of Jaguar Health Inc (NASDAQ:JAGX) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 99,557 shares of the biotechnology company’s stock, valued at approximately $141,000. Acadian Asset Management LLC owned 1.14% of Jaguar Health at the end of the most recent quarter. 5.45% of the stock is currently owned by hedge funds and other institutional investors.
Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.
See Also: What is a Leveraged Buyout (LBO)?
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.